Current
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 Influenza Season
MMWR; August 25, 2023;72(RR-2);1-25
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022–23 Influenza Season
MMWR, August 26, 2022, 71(1); 1-28
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021–22 Influenza Season
MMWR, August 27, 2021, 70(5); 1–28
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
MMWR, August 21, 2020, 69 (8); 1–24
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
MMWR, August 23, 2019, 68(3); 1–21
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2018–19 Influenza Season
MMWR, August 24, 2018, 67(3); 1-20
Archived
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
MMWR, June 8, 2018; 67 (22); 643–645
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
MMWR, August 25, 2017, 66(2); 1–20
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2016–17 Influenza Season
MMWR, August 26, 2016, Vol. 65(5):1-54
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season
MMWR, August 7, 2015; 64(30):818-825
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
MMWR, August 15, 2014; 63(327):691–697
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
MMWR, September 20, 2013; 62(RR–7):1-48
Archived
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
MMWR, May 10, 2013; 62(18):356
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
MMWR, August 18, 2012;61(32);613-8
Archived
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
MMWR, January 21, 2011; 60(RR01):1-24
Archived
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
MMWR, April 30, 2010; 59(16):485-486
Archived
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
MMWR, November 23, 2007; 56(46):1217-1219
Archived
Influenza Vaccination of Health-Care Personnel
MMWR, February 24, 2006, Vol. 55(RR02):1-16
Archived
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
